CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) |
Total shareholder's equity |
Preferred shares |
Ordinary shares |
Additional paid-in capital |
[1] | Statutory reserve |
Retained earnings / (accumulated deficit) |
Accumulated other comprehensive (loss)/income |
Non-controlling interests |
Total |
|||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance at beginning at Dec. 31, 2022 | $ 25,932,857 | $ 2,059 | [1] | $ 18,850,677 | $ 4,395,319 | $ 3,961,236 | $ (1,276,434) | $ (155,594) | $ 25,777,263 | ||||
| Balance at beginning (in shares) at Dec. 31, 2022 | [1] | 20,588,236 | |||||||||||
| Increase (Decrease) in Stockholders' Equity | |||||||||||||
| Net income (loss) | 10,545,978 | 10,545,978 | 112,205 | 10,658,183 | |||||||||
| Appropriation of statutory reserve | 113,047 | (113,047) | 100,000 | ||||||||||
| Foreign currency translation adjustments | (728,688) | (728,688) | (728,688) | ||||||||||
| Balance at ending at Dec. 31, 2023 | 35,750,147 | $ 2,059 | [1] | 18,850,677 | 4,508,366 | 14,394,167 | (2,005,122) | (43,389) | 35,706,758 | ||||
| Balance at ending (in shares) at Dec. 31, 2023 | [1] | 20,588,236 | |||||||||||
| Increase (Decrease) in Stockholders' Equity | |||||||||||||
| Net income (loss) | 12,453,369 | 12,453,369 | 144,729 | 12,598,098 | |||||||||
| PIPE financing | 2,900,000 | $ 29 | 2,899,971 | 2,900,000 | |||||||||
| PIPE financing (in shares) | 290,000 | ||||||||||||
| Capitalization of PIPE financing costs | (2,900,000) | (2,900,000) | (2,900,000) | ||||||||||
| Reverse Recapitalization transaction (in shares) | [1] | 4,966,860 | |||||||||||
| Reverse Recapitalization transaction | (7,408,439) | $ 497 | [1] | (7,408,936) | (7,408,439) | ||||||||
| Appropriation of statutory reserve | 82,785 | (82,785) | 80,000.00 | ||||||||||
| Foreign currency translation adjustments | (1,135,939) | (1,135,939) | (1,135,939) | ||||||||||
| Balance at ending at Dec. 31, 2024 | 39,659,138 | $ 29 | $ 2,556 | [1] | 11,441,712 | 4,591,151 | 26,764,751 | (3,141,061) | 101,340 | 39,760,478 | |||
| Balance at ending (in shares) at Dec. 31, 2024 | 290,000 | 25,555,096 | [1] | ||||||||||
| Increase (Decrease) in Stockholders' Equity | |||||||||||||
| Net income (loss) | (27,278,005) | (27,278,005) | (263,119) | (27,541,124) | |||||||||
| Stock-based compensation to individuals | 13,277,119 | $ 456 | [1] | 13,276,663 | 13,277,119 | ||||||||
| Stock-based compensation to individuals (in shares) | [1] | 4,563,745 | |||||||||||
| Stock-based payment to third-party companies | 4,193,962 | $ 63 | [1] | 4,193,899 | 4,193,962 | ||||||||
| Stock-based payment to third-party companies (in shares) | [1] | 633,529 | |||||||||||
| Accrual of PIPE dividend | (253,750) | (253,750) | (253,750) | ||||||||||
| Appropriation of statutory reserve | 2,161 | (2,161) | 2,161 | ||||||||||
| Foreign currency translation adjustments | 1,769,167 | 1,769,167 | 17,690 | 1,786,857 | |||||||||
| Balance at ending at Dec. 31, 2025 | $ 31,367,631 | $ 29 | $ 3,075 | [1] | $ 28,658,524 | $ 4,593,312 | $ (515,415) | $ (1,371,894) | $ (144,089) | $ 31,223,542 | |||
| Balance at ending (in shares) at Dec. 31, 2025 | 290,000 | 30,752,370 | [1] | ||||||||||
| |||||||||||||
| X | ||||||||||
- Definition Amount of decrease in additional paid in capital (APIC) resulting from transaction costs associated with reverse recapitalization. No definition available.
|
| X | ||||||||||
- Definition The amount of appropriations in statutory reserve made during the period. No definition available.
|
| X | ||||||||||
- Definition The number of shares issued in private investment in public equity financing during the period. No definition available.
|
| X | ||||||||||
- Definition Number of shares issued upon reverse recapitalization transaction during the period. No definition available.
|
| X | ||||||||||
- Definition Equity impact of the value of private investment in public equity financing during the period. No definition available.
|
| X | ||||||||||
- Definition Amount of decrease in additional paid in capital (APIC) resulting from dividends legally declared (or paid) in excess of retained earnings balance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|